PRPH OTC
ProPhase Labs, Inc.
1W: +43.6%
1M: -21.8%
3M: -78.5%
YTD: -95.6%
1Y: -99.7%
3Y: -99.9%
5Y: -99.9%
$0.02
+0.00 (+31.67%)
Weekly Expected Move ±35.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
28 relationships28
As Filer
counterparties named
0
As Counterparty
mentioned by others
7
Rel. Types
2021-08-16
Earliest Filing
2026-01-23
Latest Filing
target: 6
partner: 6
acquirer: 6
customer: 4
investor: 2
licensee: 2
supplier: 2
Counterparties (Filed by PRPH)
28 relationshipsCompanies named in PRPH's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Generating Alpha Ltd. | — | investor | Investor purchasing common stock from the Company | 2026-01-23 | View |
| ProPhase Labs Inc. | PRPH | target | Company issuing and selling common stock to the Investor | 2026-01-23 | View |
| WestPark Capital, Inc. | — | partner | Exclusive placement agent for the issuance and sale of Placement Shares. | 2025-10-15 | View |
| ProPhase Labs, Inc. | PRPH | target | Company entering into bridge loan agreement | 2025-06-27 | View |
| Nebula Genomics, Inc. | — | partner | Wholly owned subsidiary whose sale proceeds are anticipated to repay financing | 2025-06-27 | View |
| Crown Medical Collections | CCK | customer | Entity owed accounts receivable by diagnostic laboratory subsidiary | 2025-06-27 | View |
| Keystone Capital Partners, LLC | — | investor | Investor purchasing newly issued common stock from the Company | 2025-01-30 | View |
| ProPhase Labs, Inc. | PRPH | target | Company issuing and selling common stock to the Investor | 2025-01-30 | View |
| ProPhase Labs, Inc. | PRPH | acquirer | Issuer of common stock in underwriting agreement | 2024-11-13 | View |
| ThinkEquity LLC | — | partner | Representative of the several underwriters | 2024-11-13 | View |
| ProPhase Labs, Inc. | PRPH | customer | Company issuing the promissory note and guarantor | 2024-08-21 | View |
| Prophase Labs, Inc. | PRPH | acquirer | Party entering into Standstill Agreement | 2024-04-18 | View |
| ThinkEquity LLC | — | partner | Sales Agent and Party entering into Standstill Agreement | 2024-04-18 | View |
| ProPhase Labs, Inc. | PRPH | customer | Company issuing the promissory note and receiving the loan | 2023-01-30 | View |
| Pharmaloz Manufacturing, Inc. | — | partner | Entity providing an unconditional guarantee for the loan | 2023-01-30 | View |
| Stella Diagnostics Inc. | — | target | Seller of assets and business | 2022-12-20 | View |
| Stella DX, LLC | — | target | Seller of assets and business | 2022-12-20 | View |
| ProPhase Labs, Inc. | PRPH | acquirer | Purchaser of assets and business | 2022-12-20 | View |
| ProPhase BioPharma, Inc. | — | licensee | Licensee obtaining rights to exploit licensed compound and products | 2022-07-21 | View |
| Global BioLife, Inc. | — | licensee | Licensor granting rights to exploit licensed compound and products | 2022-07-21 | View |
| GRDG Sciences, LLC | — | partner | Entity providing know-how and collaborating on development | 2022-07-21 | View |
| UNIT 2 ASSOCIATES L.L.C. | — | supplier | Co-landlord leasing office space | 2022-06-13 | View |
| PROPHASE DIAGNOSTICS, INC. | — | customer | Tenant leasing office space | 2022-06-13 | View |
| BRG OFFICE L.L.C. | — | supplier | Landlord leasing office space | 2022-06-13 | View |
| ProPhase Labs, Inc. | PRPH | acquirer | Company repaying convertible note obligations and repurchasing shares from holder. | 2022-03-02 | View |
| Nebula Genomics, Inc. | — | target | Target company in the stock purchase agreement. | 2021-08-16 | View |
| ProPhase Labs, Inc. | PRPH | acquirer | Parent company of the buyer in the stock purchase agreement. | 2021-08-16 | View |
| ProPhase Precision Medicine, Inc. | — | acquirer | Wholly owned subsidiary of ProPhase Labs, Inc. acting as the buyer in the stock purchase agreement. | 2021-08-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-02-13 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-13 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-27 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-23 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2026-01-23 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-09 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-01-09 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-02 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-12-19 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-19 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-18 | Amendments to Articles of Incorporation or Bylaws; Other Events; Financial Statements and Exhibits | View | |
| 2025-12-12 | Amendments to Articles of Incorporation or Bylaws; Other Events; Financial Statements and Exhibits | View | |
| 2025-12-12 | Amendments to Articles of Incorporation or Bylaws; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-26 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-11-25 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-11-25 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-19 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-15 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-09-18 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR